Literature DB >> 10591410

Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation.

M Sitges1, V Nekrassov.   

Abstract

The effects of vinpocetine on internal Na+ (Na(i)), cAMP accumulation, internal Ca2+ (Ca(i)) and excitatory amino acid neurotransmitters release, under resting and under depolarized conditions, was investigated in rat striatum synaptosomes. Veratridine (20 microM) or high K+ (30 mM) were used as depolarizing agents. Results show that vinpocetine in the low microM range inhibits the elevation of Na(i), the elevation of Ca(i) and the release of glutamate and aspartate induced by veratridine depolarization. In contrast, vinpocetine fails to inhibit the rise of Ca(i) and the neurotransmitter release induced by high K+, which are both TTX insensitive responses. Results also show that the inhibition exerted by vinpocetine on all the above veratridine-induced responses is not reflected in PDE activity. Our interpretation of these results is that vinpocetine inhibits neurotransmitter release triggered by veratridine activation of voltage sensitive Na+ channels, but not that triggered by a direct activation of VSCC. Thus, the main mechanism involved in the neuroprotective action of vinpocetine in the CNS is unlikely to be due to a direct inhibition of Ca2+ channels or PDE enzymes, but rather the inhibition of presynaptic Na+ channel-activation unchained responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10591410     DOI: 10.1023/a:1021164418478

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  36 in total

1.  Protein kinase A reduces voltage-dependent Na+ current in Xenopus oocytes.

Authors:  E Gershon; L Weigl; I Lotan; W Schreibmayer; N Dascal
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

2.  Calcium channels coupled to glutamate release identified by omega-Aga-IVA.

Authors:  T J Turner; M E Adams; K Dunlap
Journal:  Science       Date:  1992-10-09       Impact factor: 47.728

3.  Study on the possible involvement of protein kinases in the modulation of brain presynaptic sodium channels; comparison with calcium channels.

Authors:  M Sitges; F Peña; L M Chiu; A Guarneros
Journal:  Neurochem Int       Date:  1998-02       Impact factor: 3.921

4.  Depolarization of rat brain synaptosomes increases phosphorylation of voltage-sensitive sodium channels.

Authors:  T Kondratyuk; S Rossie
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

5.  Comparative neuroprotective effects of pentobarbital, vinpocetine, flunarizine and ifenprodil on ischemic neuronal damage in the gerbil hippocampus.

Authors:  T Araki; K Kogure; K Nishioka
Journal:  Res Exp Med (Berl)       Date:  1990

6.  Vinpocetine prevents ischemic cell damage in rat hippocampus.

Authors:  D Sauer; R Rischke; T Beck; C Rossberg; H D Mennel; G W Bielenberg; J Krieglstein
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

7.  omega-Aga IVA selectively inhibits the calcium-dependent fraction of the evoked release of [3H]GABA from synaptosomes.

Authors:  M Sitges; L M Chiu
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

8.  Vincamine and vincanol are potent blockers of voltage-gated Na+ channels.

Authors:  S A Erdo; P Molnár; V Lakics; J Z Bence; Z Tömösközi
Journal:  Eur J Pharmacol       Date:  1996-10-24       Impact factor: 4.432

9.  Hippocampal slices: glutamate overflow and cellular damage from ischemia are reduced by sodium-channel blockade.

Authors:  C P Taylor; S P Burke; M L Weber
Journal:  J Neurosci Methods       Date:  1995-06       Impact factor: 2.390

10.  Phosphorylation of calmodulin on Tyr99 selectively attenuates the action of calmodulin antagonists on type-I cyclic nucleotide phosphodiesterase activity.

Authors:  M K Saville; M D Houslay
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

View more
  10 in total

Review 1.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 2.  An update on vinpocetine: New discoveries and clinical implications.

Authors:  Yi-Shuai Zhang; Jian-Dong Li; Chen Yan
Journal:  Eur J Pharmacol       Date:  2017-11-26       Impact factor: 4.432

3.  The nootropic drug vinpocetine inhibits veratridine-induced [Ca2+]i increase in rat hippocampal CA1 pyramidal cells.

Authors:  T Zelles; L Franklin; I Koncz; B Lendvai; G Zsilla
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

4.  A phenotypic screening platform to identify small molecule modulators of Chlamydomonas reinhardtii growth, motility and photosynthesis.

Authors:  Simon E Alfred; Anuradha Surendra; Chris Le; Ken Lin; Alexander Mok; Iain M Wallace; Michael Proctor; Malene L Urbanus; Guri Giaever; Corey Nislow
Journal:  Genome Biol       Date:  2012-11-18       Impact factor: 13.583

5.  Characterization of the participation of sodium channels on the rise in Na+ induced by 4-aminopyridine (4-AP) in synaptosomes.

Authors:  Emilio Galván; María Sitges
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

6.  Dihydropiridines mechanism of action in striatal isolated nerve endings: comparison with omega-agatoxin IVA.

Authors:  C A Galindo; M Sitges
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

7.  Characterization of phenytoin, carbamazepine, vinpocetine and clorgyline simultaneous effects on sodium channels and catecholamine metabolism in rat striatal nerve endings.

Authors:  María Sitges; Blanca I Aldana; Luz M Chiu; Vladimir Nekrassov
Journal:  Neurochem Res       Date:  2008-08-19       Impact factor: 3.996

8.  Effect of the Anti-depressant Sertraline, the Novel Anti-seizure Drug Vinpocetine and Several Conventional Antiepileptic Drugs on the Epileptiform EEG Activity Induced by 4-Aminopyridine.

Authors:  Maria Sitges; Blanca Irene Aldana; Ronald Charles Reed
Journal:  Neurochem Res       Date:  2016-01-30       Impact factor: 3.996

9.  Vinpocetine reduces carrageenan-induced inflammatory hyperalgesia in mice by inhibiting oxidative stress, cytokine production and NF-κB activation in the paw and spinal cord.

Authors:  Kenji W Ruiz-Miyazawa; Ana C Zarpelon; Felipe A Pinho-Ribeiro; Gabriela F Pavão-de-Souza; Rubia Casagrande; Waldiceu A Verri
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

10.  Updates of Recent Vinpocetine Research in Treating Cardiovascular Diseases.

Authors:  Chongyang Zhang; Chen Yan
Journal:  J Cell Immunol       Date:  2020
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.